About: covid:PMC7273249

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: covid:PMC7273249 Goto Sponge NotDistinct Permalink

An Entity of Type : owl:Thing, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
Creator	Khera, Rohan Lin, Zhenqiu Krumholz, Harlan Omer, Saad Vojta, Deneen Clark, Callahan Guo, Yinglong Lu, Yuan Murugiah, Karthik Ren, Sheng Spatz, Erica Truax, Brandon
is schema:about of	named entity 'Risk' named entity 'Inhibitors' named entity 'ACE inhibitors' named entity 'chronic pulmonary disease' named entity 'ACE inhibitors' named entity 'COVID-19' named entity 'comorbidities' named entity 'chronic kidney disease' named entity 'ARBs' named entity 'severe liver disease' named entity 'ARBs' named entity 'ACE inhibitors' named entity 'anti-hypertensive' named entity 'pneumonia' named entity 'pneumonia' named entity 'SARS-CoV-2' named entity 'antihypertensive agents' named entity 'binding site' named entity 'Medicare Advantage' named entity 'ACE inhibitors' named entity 'outpatient' named entity 'ACE inhibitor' named entity 'ARBs' named entity 'Medicare Advantage' named entity 'ARBs' named entity 'dementia' named entity 'diabetes' named entity 'ARBs' named entity 'COVID-19' named entity 'angiotensin-converting enzyme (ACE) inhibitors' named entity 'vasodilators' named entity 'COVID' named entity 'COVID' named entity 'ARBs' named entity 'ACE inhibitors' named entity 'ARBs' named entity 'drug therapy' named entity 'chronic heart failure' named entity 'antihypertensive agents' named entity 'outpatient' named entity 'COVID' named entity 'cell cultures' named entity 'SARS' named entity 'standard deviation' named entity 'ACE inhibitor' named entity 'COVID-19 disease' named entity 'ACE2' named entity 'COVID' named entity 'hypertension' named entity 'anti-hypertensive' named entity 'ACE inhibitors' named entity 'hypertension' named entity 'antihypertensive agent' named entity 'SARS-CoV-2' named entity 'level of significance' named entity 'ACE inhibitor' named entity 'SARS-CoV-2' named entity 'Proportional Hazards model' named entity 'infection' named entity 'covariate' named entity 'drug treatment' named entity 'alpha blockers' named entity 'ACE inhibitors' named entity 'ARBs' named entity 'SARS-CoV-2' named entity 'multiple testing' named entity 'ACE inhibitors' named entity 'lab testing' named entity 'Chi square test' named entity 'virus entry' named entity 'infection' named entity 'ACE inhibitors' named entity 'hypertension' named entity 'health centers' named entity 'outpatient setting' named entity 'UnitedHealth Group' named entity 'SARS-CoV-2' named entity 'solid tumor' named entity 'ACE inhibitors' named entity 'comorbidities' named entity 'ACE inhibitors' named entity 'ARBs' named entity 'peripheral vascular disease' named entity 'propensity score matching' named entity 'ACE inhibitors' named entity 'Proportional Hazards models' named entity 'inpatient, outpatient' named entity 'Institutional Review Board'

Attributes

Values

Creator

Khera, Rohan
Lin, Zhenqiu
Krumholz, Harlan
Omer, Saad
Vojta, Deneen
Clark, Callahan
Guo, Yinglong
Lu, Yuan
Murugiah, Karthik
Ren, Sheng
Spatz, Erica
Truax, Brandon

is schema:about of

named entity 'Risk'
named entity 'Inhibitors'
named entity 'ACE inhibitors'
named entity 'chronic pulmonary disease'
named entity 'ACE inhibitors'
named entity 'COVID-19'
named entity 'comorbidities'
named entity 'chronic kidney disease'
named entity 'ARBs'
named entity 'severe liver disease'
named entity 'ARBs'
named entity 'ACE inhibitors'
named entity 'anti-hypertensive'
named entity 'pneumonia'
named entity 'pneumonia'
named entity 'SARS-CoV-2'
named entity 'antihypertensive agents'
named entity 'binding site'
named entity 'Medicare Advantage'
named entity 'ACE inhibitors'
named entity 'outpatient'
named entity 'ACE inhibitor'
named entity 'ARBs'
named entity 'Medicare Advantage'
named entity 'ARBs'
named entity 'dementia'
named entity 'diabetes'
named entity 'ARBs'
named entity 'COVID-19'
named entity 'angiotensin-converting enzyme (ACE) inhibitors'
named entity 'vasodilators'
named entity 'COVID'
named entity 'COVID'
named entity 'ARBs'
named entity 'ACE inhibitors'
named entity 'ARBs'
named entity 'drug therapy'
named entity 'chronic heart failure'
named entity 'antihypertensive agents'
named entity 'outpatient'
named entity 'COVID'
named entity 'cell cultures'
named entity 'SARS'
named entity 'standard deviation'
named entity 'ACE inhibitor'
named entity 'COVID-19 disease'
named entity 'ACE2'
named entity 'COVID'
named entity 'hypertension'
named entity 'anti-hypertensive'
named entity 'ACE inhibitors'
named entity 'hypertension'
named entity 'antihypertensive agent'
named entity 'SARS-CoV-2'
named entity 'level of significance'
named entity 'ACE inhibitor'
named entity 'SARS-CoV-2'
named entity 'Proportional Hazards model'
named entity 'infection'
named entity 'covariate'
named entity 'drug treatment'
named entity 'alpha blockers'
named entity 'ACE inhibitors'
named entity 'ARBs'
named entity 'SARS-CoV-2'
named entity 'multiple testing'
named entity 'ACE inhibitors'
named entity 'lab testing'
named entity 'Chi square test'
named entity 'virus entry'
named entity 'infection'
named entity 'ACE inhibitors'
named entity 'hypertension'
named entity 'health centers'
named entity 'outpatient setting'
named entity 'UnitedHealth Group'
named entity 'SARS-CoV-2'
named entity 'solid tumor'
named entity 'ACE inhibitors'
named entity 'comorbidities'
named entity 'ACE inhibitors'
named entity 'ARBs'
named entity 'peripheral vascular disease'
named entity 'propensity score matching'
named entity 'ACE inhibitors'
named entity 'Proportional Hazards models'
named entity 'inpatient, outpatient'
named entity 'Institutional Review Board'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software